|Abbott Laboratories, of Abbott Park, Ill.||Heartmate 3||Implantable mechanical circulatory support device||Patients with advanced refractory left ventricular heart failure||The U.S. FDA approved updated labeling to allow for use in pediatric patients|
|Cerenion Oy, of Oulu, Finland||C-Trend||Artificial intelligence software integrated into the Bittium Brainstatus EEG system||Processes EEG signals into diagnostic score||Received the CE mark|
|Ecolab Inc., of St. Paul, Minn.||Bioquell technology system||Uses hydrogen peroxide vapor technology||For decontaminating specific N95 respirators up to 4 times to prevent exposure to SARS-CoV-2 and other pathogenic biological airborne particulate||Received emergency use authorization from the U.S. FDA|
|Integrum AB, of Mölndal, Sweden||Osseoanchored Prostheses for the Rehabilitation of Amputees (OPRA)||Implant system||For adults who have transfemoral (above-the-knee) amputations||Received premarket approval from the U.S. FDA|
|Occlutech International AB, of Helsingborg, Sweden||Atrial flow regulator||Implantable device||For pulmonary arterial hypertension||Received breakthrough device designation from the U.S. FDA|
For more information about individual companies and/or products, see Cortellis.